News

StockStory.org on MSN14h
Winners And Losers Of Q1: Repligen (NASDAQ:RGEN) Vs The Rest Of The Drug Development Inputs & Services Stocks
Let’s dig into the relative performance of Repligen (NASDAQ:RGEN) and its peers as we unravel the now-completed Q1 drug ...
The New York Times20h
New York Times - Top Stories
Putin Plans to Retaliate Against Ukraine’s Surprise Attack, Trump Says Vladimir Putin told President Trump he planned to retaliate against Ukraine for its drone attack. Mr. Trump did not say ...